Ayoub, B.M.; Michel, H.E.; Mowaka, S.; Hendy, M.S.; Tadros, M.M.
Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. Molecules 2021, 26, 889.
https://doi.org/10.3390/molecules26040889
AMA Style
Ayoub BM, Michel HE, Mowaka S, Hendy MS, Tadros MM.
Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. Molecules. 2021; 26(4):889.
https://doi.org/10.3390/molecules26040889
Chicago/Turabian Style
Ayoub, Bassam M., Haidy E. Michel, Shereen Mowaka, Moataz S. Hendy, and Mariam M. Tadros.
2021. "Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS" Molecules 26, no. 4: 889.
https://doi.org/10.3390/molecules26040889
APA Style
Ayoub, B. M., Michel, H. E., Mowaka, S., Hendy, M. S., & Tadros, M. M.
(2021). Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. Molecules, 26(4), 889.
https://doi.org/10.3390/molecules26040889